RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 61 filers reported holding RECRO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,628 | -57.4% | 12,000 | 0.0% | 0.00% | – |
| Q2 2023 | $13,200 | -7.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2023 | $14,280 | -20.1% | 12,000 | 0.0% | 0.00% | – |
| Q4 2022 | $17,880 | -38.3% | 12,000 | -33.6% | 0.00% | – |
| Q3 2022 | $29,000 | +107.1% | 18,081 | +0.4% | 0.00% | – |
| Q2 2022 | $14,000 | -56.2% | 18,000 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | +3.2% | 18,000 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -16.2% | 18,000 | 0.0% | 0.00% | – |
| Q3 2021 | $37,000 | -11.9% | 18,000 | 0.0% | 0.00% | – |
| Q2 2021 | $42,000 | -16.0% | 18,000 | 0.0% | 0.00% | – |
| Q1 2021 | $50,000 | -2.0% | 18,000 | 0.0% | 0.00% | – |
| Q4 2020 | $51,000 | +34.2% | 18,000 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -53.7% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $82,000 | -61.1% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $211,000 | -36.1% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $330,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |